Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABVC
ESLA
Add up to 3 more stocks
ABVC
ABVC BioPharma, Inc.
-2.04%
$0.96-0.02Delayed quote: Oct 6, 2026, 11:41 AM EDT
Market Cap
$24.96M
52W Range
$0.71 - $3.40
ESLA
Estrella Immunopharma, Inc.
-1.98%
$0.43-0.01Delayed quote: Oct 6, 2026, 11:38 AM EDT
Market Cap
$18.40M
52W Range
$0.43 - $3.15
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.43 | N/A |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -76.8% | N/A |
| ROA | -40.7% | -548.7% |
| ROIC | -53.3% | N/A |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.07 | 0.20 |
| Quick Ratio | 0.07 | 0.20 |
| Debt/Equity | 0.17 | N/A |
| Interest Coverage | -17.20 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.